Early Antibiotic Use May Halt Progression of Severe Respiratory Illness in Young Children
Researchers from Washington University in Saint Louis School of Medicine, studied more than 600 children, ranging from ages one to six years old, with a history of repeated episodes of severe respiratory illness. Children were randomly assigned to either receive azithromycin or a placebo early in these episodes.
They found that children in the antibiotic group experienced a lower risk of progressing to severe LRTI than the placebo group.
PRESS RELEASE DOWNLOAD
The JAMA Network Media Relations-United Statesmediarelations@jamanetwork.org3124645262